Clinical Faculty Bio
Angela Yetman, M.D.Angela Yetman, M.D.
Professor, Internal Medicine and Pediatric Cardiology
Division of Cardiovascular Medicine

 
Academic offices:
Department of Internal Medicine
982265 Nebraska Medical Center
Omaha, NE 68198-2265

Children’s Hospital & Medical Center
8200 Dodge Street
Omaha, NE 68114
 
Practice Locations:
Omaha, Nebraska
Kearney, Nebraska 

Hospital Appointments:
Nebraska Medicine
 
Board Certification:
Pediatrics
Pediatric Cardiology
 
Education:

McMaster Medical School (Hamilton Canada)  Doctor of Medicine 1991

University of Western Ontario (London Canada) Resident Internal Medicine/Pediatrics 1994

University of Toronto/Hospital for Sick Children (Toronto Canada) Fellow Pediatric Cardiology 1997

Biographical Sketch:
Dr. Yetman is an academic cardiologist who has focused her career in the area of congenital heart disease and diseases of the aorta.  She has served in leadership roles across the country creating specialized clinics for the care of patients with Marfan syndrome and other aortic diseases as well as specialized clinics for girls and women with Turner syndrome.  Prior to coming to Omaha in 2014, she was the director of the Adult Congenital Cardiology clinic in Salt Lake City Utah from 2006-2013 and in Denver Colorado from 2002-2006.  


Clinical Expertise:
Dr. Yetman’s clinical interests include the care of adolescents with congenital heart disease, care of patients of all ages with Marfan syndrome,aortic aneurysms, bicuspid aortic valve and Turner syndrome.  She has over 20 years of experience caring for patients with these disorders and sees patients from across the country with Marfan syndrome and other disorders of the aorta. She works closely with members of our cardiothoracic surgery and vascular surgery divisions to provide comprehensive care to patients with aortic disease.  

Research Expertise:
Dr.Yetman was actively involved in the international trial of Atenolol versus Losartan in patients with Marfan syndrome.  Her primary research interests are in aortic disease,  and in  women’s health.

Selected Publications:

Cardiovascular and general health status of adults with Trisomy 21.

Hayes SA, Kutty S, Thomas J, Johnson JT, Yetman AT. Int J Cardiol. 2017 Mar 10. pii: S0167-5273(16)32518-9. doi: 10.1016/j.ijcard.2017.03.040. [Epub ahead of print]

PMID:28318659

Progressive Aortic Dilation Associated With ACTA2 Mutations Presenting in Infancy.

Yetman AT, Starr LJ, Bleyl SB, Meyers L, Delaney JW.

Pediatrics. 2015 Jul;136(1):e262-6. doi: 10.1542/peds.2014-3032. Epub 2015 Jun 1.

Impact of liver disease after the fontan operation.

Lindsay I, Johnson J, Everitt MD, Hoffman J, Yetman AT. Am J Cardiol. 2015 Jan 15;115(2):249-52. doi: 10.1016/j.amjcard.2014.10.032. Epub 2014 Oct 30. PMID:25534765

Atenolol versus losartan in children and young adults with Marfan's syndrome.

Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, Pearson GD, Selamet Tierney ES, Levine JC, Atz AM, Benson DW, Braverman AC, Chen S, De Backer J, Gelb BD, Grossfeld PD, Klein GL, Lai WW, Liou A, Loeys BL, Markham LW, Olson AK, Paridon SM, Pemberton VL, Pierpont ME, Pyeritz RE, Radojewski E, Roman MJ, Sharkey AM, Stylianou MP, Wechsler SB, Young LT, Mahony L; Pediatric Heart Network Investigators..N Engl J Med. 2014 Nov 27;371(22):2061-71. doi: 10.1056/NEJMoa1404731. Epub 2014 Nov 18.PMID:25405392

The immediate and long-term impact of pregnancy on aortic growth rate and mortality in women with Marfan syndrome.

Donnelly RT, Pinto NM, Kocolas I, Yetman AT. J Am Coll Cardiol. 2012 Jul 17;60(3):224-9. doi: 10.1016/j.jacc.2012.03.051.PMID:22789886